Clinical
November MIMS update
Some of the recent changes to the medicines landscape, with new products, presentations, indications and contraindications New Products Elafibranor (Iqirvo) and its main active metabolite GFT1007 are peroxisome proliferator-activated receptor …
Prescriber Bag reviewed
Furosemide, Covid-19 antiviral tablets cited in PBAC recommendations on items to be added to or removed from the bag All currently listed Prescriber Bag benefits remain suitable, except Covid-19 antiviral …
‘Consistent evidence’: GPP role saves money, improves health outcomes
GP pharmacists even helped patients on GLP-1s lose twice the amount of weight, a review exploring benefits of the role has found Medication reviews comprise a huge part of the …
Rising meds costs an issue
A new study has found women who received HMRs spent more on out-of-pocket medication costs over time than those who didn’t receive one Older women paid more out-of-pocket medication costs …
October MIMS Update
Some of the recent changes to the medicines landscape, with new products, indications and contraindications New Products Capivasertib (Truqap) is an inhibitor of the kinase activity of all 3 isoforms …
Empagliflozin PBS population expanded
Eligible patients more than doubled in line with largest trial on SGLT-2 inhibitors in CKD The PBS listing of Jardiance (empagliflozin 10mg) will be significantly expanded to include a broader …
Shortages, discontinuations seeing people on multiple medications
Semaglutide scarcity and other similar shortages have led to people doubling up on treatments, says diabetes educator and pharmacist Medicines shortages and discontinuations are leading to people concurrently taking multiple …
Oral versions of GLP-1s on the horizon
With benefits beyond glucose control for the “new kid on the block” in diabetes management, leading researcher foreshadows oral versions with less side effects New versions of GLP-1 receptor agonists …
Triple therapy, SABA market growing
What is the cost and utilisation of the inhaler therapies market? Drug utilisation sub-committee investigates the numbers A PBS committee has considered whether reversion to Authority Required (telephone/online) may be …
Two new strains for 2026 flu vaccines
Australian committee releases recommendations for next round of influenza vaccines, with differences to this year’s southern hemisphere and 2025/26 northern hemisphere recommendations The Australian Influenza Vaccine Committee (AIVC) has recommended …
Two suspected overdose cases in infants
TGA issues warning over topical prilocaine/lidocaine cream after receiving notifications for serious adverse events The TGA is reminding health professionals and parents to “use no more than the recommended amount” …
September MIMS update
Some of the recent changes to the medicines landscape, with new products, indications and contraindications New Products • Albutrepenonacog alfa (Idelvion) is a recombinant fusion protein linking recombinant coagulation factor …